Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities
Sabuj
Kanti Das
a,
Snehasis
Mishra
b,
Krishnendu
Manna
b,
Utpal
Kayal
a,
Supratim
Mahapatra
b,
Krishna
Das Saha
b,
Sasanka
Dalapati
c,
G. P.
Das
a,
Amany A.
Mostafa
d and
Asim
Bhaumik
*a
aDepartment of Materials Science, Indian Association for the Cultivation of Science Jadavpur, Kolkata – 700 032, India. E-mail: msab@iacs.res.in
bCancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Jadavpur, Kolkata – 700032, India
cDepartment of Chemistry, Indian Institute of Engineering Science and Technology, Shibpur, Howrah – 711103, India
dDepartment of Ceramic, Nanomedicine & Tissue Engineering Laboratory, National Research Centre, El Bohouth St., Dokki, Cairo – 12622, Egypt
First published on 16th October 2018
Abstract
Correction for ‘A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities’ by Sabuj Kanti Das et al., Chem. Commun., 2018, 54, 11475–11478.
The authors regret that the following acknowledgements were omitted from the original article. SKD acknowledges UGC, New Delhi for a senior research fellowship. AB and AAM acknowledge DST-ASRT for an Indo-Egypt international project grant. UK would like to acknowledge DST-SERB, New Delhi for an NPDF research grant.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2018 |